KFDA Said Efficacy of Supervising Pharmaceutical Affairs was Unsatisfactory

Published: 2002-01-28 06:58:00

Updated: 2002-01-28 06:58:00

An indication that the activity of supervising pharmaceutical affairs of Korea Food & Drug Administration to strengthen the management of medicine production and distribution was unsatisfactory was raised.

According to the 2001 government work evaluation result of the Prime Minister room, it p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK